Fluifort fever and pain

Patient Information Leaflet

FLUIFORT FEVER AND PAIN Children 100 mg/5 ml oral suspension, strawberry sugar-free, orange sugar-free

Ibuprofen
Equivalent medicine
Read this leaflet carefully before using this medicine because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has instructed you.

• Keep this leaflet. You may need to read it again.
• If you need more information or advice, consult your pharmacist.
• If you experience any side effects, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.
• Consult your doctor if you do not notice improvement or if your symptoms worsen after: 24 hours in infants aged 3 to 5 months; 3 days in infants and children aged 6 months and older, and in adolescents.

Contents of this leaflet:

1. What FLUIFORT FEVER AND PAIN is and what it is used for
2. What you need to know before using FLUIFORT FEVER AND PAIN
3. How to use FLUIFORT FEVER AND PAIN
4. Possible side effects
5. How to store FLUIFORT FEVER AND PAIN
6. Contents of the pack and other information

1. What FLUIFORT FEVER AND PAIN is and what it is used for

FLUIFORT FEVER AND PAIN contains ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) with analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory properties.
FLUIFORT FEVER AND PAIN is indicated in children from 3 months to 12 years of age for the symptomatic treatment of fever, including post-vaccination fever, and mild to moderate pain (such as headache, toothache, sore throat, earache).

2. What you should know before taking FLUIFORT FEVER AND PAIN

Do not use FLUIFORT FEVER AND PAIN if the child:

• is allergic to ibuprofen or to any of the other ingredients of this medicine (listed in section 6).
• is allergic to acetylsalicylic acid or to other analgesics, antipyretics, or non-steroidal anti-inflammatory drugs (NSAIDs), especially when hypersensitivity is associated with nasal polyps (nasal polyposis) and asthma;
• suffers from active peptic ulcer;
• has reduced kidney function (severe renal insufficiency) or liver function (severe hepatic insufficiency);
• suffers from a severe heart disease (severe heart failure);
• has a history of gastrointestinal bleeding or perforation related to previous NSAID therapy, or a history of recurrent bleeding/peptic ulcer (two or more distinct episodes of proven ulceration or bleeding);
• is currently taking other NSAIDs, including selective COX-2 inhibitors;
• has any disease that increases the risk of bleeding;
• has unexplained blood disorders;
• is in a severe state of dehydration, for example due to severe episodes of vomiting, diarrhoea, or very low fluid intake;
• is under 3 months of age or weighs less than 5.6 kg;
• is in the third trimester of pregnancy (see section “Pregnancy and breastfeeding”).

Warnings and precautions
Take special care with FLUIFORT FEVER AND PAIN
Serious skin reactions have been reported with ibuprofen, including exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP).
Stop using FLUIFORT FEVER AND PAIN and contact your doctor immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
Consult your doctor or pharmacist before using FLUIFORT FEVER AND PAIN if the child:

• suffers or has suffered from drug allergy to medicines used to treat fever, pain, and inflammation (non-steroidal anti-inflammatory drugs, NSAIDs), and if the child has breathing difficulties (asthma), seasonal allergies (hay fever), nasal polyps, severe respiratory or chest problems, e.g. chronic obstructive pulmonary disease (COPD), or swelling of the face, lips, and throat (angioedema);
• is taking other medicines used to treat pain, reduce fever, and/or treat inflammation (non-steroidal anti-inflammatory drugs, NSAIDs including COX-2 inhibitors) (see section “Other medicines and FLUIFORT FEVER AND PAIN”);
• has suffered from stomach or intestinal disorders (history of ulcer), especially if complicated by bleeding or perforation, as there may be an increased risk of gastrointestinal bleeding and perforation. In such cases, your doctor may advise starting treatment with the lowest available dose and possibly using concomitant medicines that protect the stomach (misoprostol or proton pump inhibitors). This should also be considered even when taking low-dose aspirin or other medicines that may increase the risk of stomach and intestinal diseases (see section “Other medicines and FLUIFORT FEVER AND PAIN”). During treatment with all NSAIDs, at any time, with or without warning symptoms or previous history of serious gastrointestinal events, gastrointestinal bleeding, ulceration, and perforation may occur, which can be fatal. Therefore, inform your doctor of any unusual gastrointestinal symptoms (especially gastrointestinal bleeding), particularly in the early stages of treatment. If gastrointestinal bleeding or ulceration occurs, discontinue treatment with FLUIFORT FEVER AND PAIN and contact your doctor;
• suffers or has suffered from inflammatory bowel disease (ulcerative colitis, Crohn’s disease), as these conditions may worsen (see section “Possible side effects”);
• is taking medicines that could increase the risk of ulcer or bleeding, such as medicines used to treat inflammation and certain immune system disorders (oral corticosteroids), anticoagulants such as warfarin, medicines with antiplatelet effects like aspirin, or medicines used to treat depression (selective serotonin reuptake inhibitors) (see section “Other medicines and FLUIFORT FEVER AND PAIN”);
• has heart diseases (uncontrolled hypertension, congestive heart failure, established ischemic heart disease, peripheral arterial disease) or has suffered from reduced blood flow to the brain (stroke), or if you think the child may be at risk for these conditions (e.g. if the child has high blood pressure, elevated blood sugar levels (diabetes), high blood lipid levels, or smokes). Medicines like FLUIFORT FEVER AND PAIN may be associated with a slight increase in the risk of heart attack or reduced blood flow to the brain: the risk is higher at high doses and with prolonged treatment. Do not exceed the recommended dose or duration of treatment;
• suffers or has suffered from high blood pressure and/or severe heart disease (heart failure), as fluid retention, high blood pressure, and swelling (oedema) have been reported in association with NSAID therapy;
• experiences skin reactions (exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis);
• has chickenpox, as in this case, it is recommended to avoid using FLUIFORT FEVER AND PAIN;
• has an infection – see section «Infections» below.

Signs of an allergic reaction to ibuprofen, including breathing problems, facial and neck swelling (angioedema), and chest pain, have been reported. Immediately stop taking FLUIFORT FEVER AND PAIN and contact your doctor or emergency medical services if you notice any of these signs.
The use of FLUIFORT FEVER AND PAIN requires adequate precautions, especially if the child:

• suffers or has suffered from asthma, as breathing difficulties may worsen;
• has blood clotting disorders;
• suffers from kidney, heart, liver diseases, or hypertension;
• is taking medicines that increase urine production (diuretics), or has undergone major surgery with significant fluid loss, in which case your doctor may recommend periodic blood and urine tests;
• has undergone major surgery;
• suffers from certain congenital disorders affecting blood formation (e.g. acute intermittent porphyria);
• is dehydrated (e.g. due to fever, vomiting, or diarrhoea); in this case, rehydrate the child before and during treatment to avoid the risk of impaired kidney function.

During prolonged treatment with FLUIFORT FEVER AND PAIN, pay particular attention and immediately inform your doctor if any of the following signs or symptoms appear:

• signs or symptoms of stomach or intestinal ulceration or bleeding (e.g. black, tarry, foul-smelling stools, vomiting blood);
• signs or symptoms of liver damage (e.g. hepatitis, jaundice);
• signs or symptoms of kidney damage (e.g. increased urine production, blood in urine);
• visual disturbances (blurred or reduced vision, areas of complete or partial blindness, altered colour perception);
• symptoms such as frequent or daily headaches despite regular use of headache medicines, which could be caused by excessive use of these medicines;
• symptoms such as headache, disorientation, nausea, vomiting, stiff neck, and fever, as these could indicate aseptic meningitis (more common if the child has a chronic autoimmune connective tissue disease affecting joints, kidneys, skin, mucous membranes, and blood vessel walls (systemic lupus erythematosus) or other connective tissue diseases (collagenoses)).

Infections
FLUIFORT FEVER AND PAIN may mask symptoms of infections such as fever and pain. Therefore, FLUIFORT FEVER AND PAIN could delay appropriate treatment of the infection, potentially increasing the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections associated with chickenpox. If you take this medicine while having an infection and infection symptoms persist or worsen, consult your doctor immediately.
Children and adolescents
In dehydrated children and adolescents, there is a risk of impaired kidney function.
Other medicines and FLUIFORT FEVER AND PAIN
Inform your doctor or pharmacist if the child is taking, has recently taken, or might take any other medicines.
FLUIFORT FEVER AND PAIN may affect or be affected by other medicines. In particular, inform your doctor or pharmacist if the child is taking:

• other medicines used to treat pain, reduce fever, and/or treat inflammation (non-steroidal anti-inflammatory drugs, NSAIDs including COX-2 inhibitors or acetylsalicylic acid). In such cases, these combinations should be avoided as they increase the risk of adverse effects;
• medicines used to treat inflammation and certain immune system disorders (corticosteroids);
• medicines used to treat bacterial infections (quinolone antibiotics);
• medicines with anticoagulant or antiplatelet effects (i.e. substances that thin the blood and prevent clotting, e.g. aspirin/acetylsalicylic acid, warfarin, ticlopidine);
• medicines used to treat depression such as selective serotonin reuptake inhibitors;
• a medicine used to treat seizures (phenytoin);
• antidiabetic medicines to treat high blood sugar levels (sulfonylureas);
• a medicine used to treat viral infections (ritonavir);
• medicines that modulate the immune response (tacrolimus and cyclosporine);
• a medicine used in the treatment of cancer and rheumatism (methotrexate);
• a medicine used for mental disorders (lithium);
• a medicine used for medical abortion (mifepristone): do not take NSAIDs within 8–10 days after taking mifepristone;
• a medicine used to treat gout (probenecid or sulfinpyrazone);
• a medicine used to treat Human Immunodeficiency Virus (HIV) infections (zidovudine);
• medicines that lower blood pressure (ACE inhibitors such as captopril, beta-blockers such as atenolol, angiotensin II antagonists such as losartan) and diuretics;
• medicines used to treat heart diseases (cardiac glycosides such as digoxin);
• potassium-sparing diuretics;
• CYP2C9 inhibitors (e.g. voriconazole, fluconazole), as concomitant administration of ibuprofen and CYP2C9 inhibitors may slow down ibuprofen elimination (a CYP2C9 substrate), leading to increased exposure to ibuprofen.

FLUIFORT FEVER AND PAIN with food and drinks
The medicine can be taken with or without food.
Possible stomach-related side effects, if present, may be reduced by taking the medicine with food.
Pregnancy, breastfeeding, and fertility
It is unlikely that individuals under 12 years of age will be pregnant or breastfeeding.
If you are pregnant, suspect you may be pregnant, are planning a pregnancy, or are breastfeeding, consult your doctor or pharmacist before taking this medicine.
Pregnancy
In such circumstances, the following considerations should be kept in mind.
Inhibition of prostaglandin synthesis may negatively affect pregnancy and/or embryonic/fetal development.
Epidemiological studies suggest an increased risk of miscarriage and of cardiac malformations and gastroschisis (abdominal wall defect with protrusion of abdominal organs) after use of a prostaglandin synthesis inhibitor during early pregnancy. The absolute risk of cardiac malformations increased from less than 1% to approximately 1.5%. It is believed that the risk increases with dose and duration of treatment.
Do not take ibuprofen during the last three months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in the fetus. It may affect bleeding tendency in both you and the baby and delay or prolong labour beyond normal. You should not take ibuprofen during the first six months of pregnancy unless strictly necessary and under medical advice. If treatment is required during this period or during attempts to conceive, the lowest effective dose for the shortest possible duration should be used. If taken for more than a few days from week 20 of pregnancy onwards, ibuprofen may cause kidney problems in the fetus, leading to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby’s heart. If treatment is required for more than a few days, your doctor may recommend additional monitoring.
Breastfeeding
This medicine passes into breast milk in small amounts. It may be used during breastfeeding if taken at the recommended doses and for short periods.
Fertility
This medicine belongs to a group of drugs (NSAIDs) that may impair fertility in women. This effect is reversible upon discontinuation of the drug.
FLUIFORT FEVER AND PAIN contains:

• Maltitol: If your doctor has diagnosed you with an intolerance to certain sugars, consult him before taking this medicine. Starting from the dose of 5 ml taken three times daily, it may have a mild laxative effect. The caloric value of maltitol is 2.3 kcal/g.
• Sodium benzoate: This medicine contains 1 mg of sodium benzoate per ml of suspension.
• Sodium: This medicine contains less than 1 mmol (23 mg) of sodium per 2.5 ml, 5 ml, 7.5 ml, 10 ml doses, i.e. essentially ‘sodium-free’. This medicine contains 30.45 mg of sodium (main component of table salt) per 15 ml dose. This corresponds to 1.52% of the maximum daily dietary intake recommended for an adult.
• Glucose (in the orange flavour present in FLUIFORT FEVER AND PAIN Children 100 mg/5 ml oral suspension, orange flavour, sugar-free).

If your doctor has diagnosed you with an intolerance to certain sugars, consult him before taking this medicine.

3. How to use FLUIFORT FEVER AND PAIN

Use this medicine exactly as stated in this leaflet or as directed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
The lowest effective dose for the shortest duration necessary to relieve symptoms should be used. If you have an infection, contact your doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).

Use in children and adolescents
FLUIFORT FEVER AND PAIN is contraindicated in children under 3 months of age or weighing less than 5.6 kg (see section "Do not take FLUIFORT FEVER AND PAIN").
The recommended dose should be selected based on the child's weight and age.
Undesirable effects can be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms.
In children aged between 3 and 6 months, limit administration to those weighing more than 5.6 kg.
Oral administration in infants and children aged between 3 months and 12 years should be performed using the dosing syringe provided with the product.
The graduated scale on the syringe clearly indicates markings for different doses; in particular, the 2.5 ml mark corresponds to 50 mg of ibuprofen, and the 5 ml mark corresponds to 100 mg of ibuprofen.
The recommended daily dose of 20–30 mg/kg of body weight, divided into three doses per day at intervals of 6–8 hours, may be administered according to the following dosing schedule (calculate the dose to be administered based on the weight and age of the child as indicated in the table below).

If the child has stomach problems, administer FLUIFORT FEVER AND PAIN preferably during meals.
In the case of post-vaccination fever, refer to the recommended daily dosage shown in the table above.
The product is intended for short-term treatment only.

Infants aged between 3 and 5 months weighing more than 5.6 kg:
In infants aged between 3 and 5 months, consult a doctor if symptoms persist for longer than 24 hours or if symptoms worsen.

Infants and children (aged between 6 months and 12 years):
If use of the medicine is required for more than 3 days in infants and children over 6 months of age, or if symptoms worsen, consult a doctor.

Instructions for using the dosing syringe:
1 Unscrew the cap by pushing it downwards and turning it to the left.
2 Insert the tip of the syringe fully into the hole in the inner cap.
3 Shake well.
4 Turn the bottle upside down, then, holding the syringe firmly, gently pull the plunger downwards to draw the suspension into the syringe until the level reaches the mark printed on the plunger corresponding to the desired dose.
5 Return the bottle to an upright position and remove the syringe by gently rotating it.
6 Insert the tip of the syringe into the child's mouth, and gently press the plunger to release the suspension.
7 After use, screw the cap back on to close the bottle and wash the syringe with warm water. Leave it to dry, keeping it out of the sight and reach of children.

If you take more FLUIFORT FEVER AND PAIN than you should
If your child has taken more FLUIFORT FEVER AND PAIN than they should, or if this medicine has been taken by mistake, always contact a doctor or the nearest hospital for advice on the risk and guidance on actions to take.
Symptoms of overdose may include nausea, stomach ache, vomiting (possibly with traces of blood), deep sleep with reduced response to normal stimuli (lethargy), headache, ringing in the ears (tinnitus), confusion, and uncontrolled eye movements. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, seizures (especially in children), weakness, dizziness, blood in the urine, low blood potassium levels, feeling cold, and breathing problems may occur.
If your child has taken an excessive dose (overdose) of ibuprofen, the following symptoms are more commonly observed: nausea, vomiting, stomach pain, deep sleep with reduced response to normal stimuli (lethargy), drowsiness, headache, dizziness, ringing in the ears (tinnitus), uncontrolled body movements (seizures), and loss of consciousness. Symptoms of overdose may appear within 4–6 hours after taking ibuprofen.
Other possible symptoms include: increased acid levels in the blood (metabolic acidosis), lowered body temperature (hypothermia), kidney-related effects, bleeding in the stomach and intestines, profound loss of consciousness (coma), temporary interruption of breathing (apnea), diarrhoea, reduced activity of the nervous system and respiratory function, disorientation, excited state, fainting, low blood pressure (hypotension), and decreased or increased heart rate (bradycardia or tachycardia).
If your child takes significantly high doses of ibuprofen, serious damage to the kidneys and liver may occur.

If you forget to take FLUIFORT FEVER AND PAIN Do not take a double dose to make up for a forgotten dose.
If you have any doubts about the use of FLUIFORT FEVER AND PAIN, consult your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone experiences them.
If the child experiences any of the following adverse effects, STOP treatment with FLUIFORT
FEVER AND PAIN and consult a doctor immediately if you notice any of the following symptoms:

• reddish, non-elevated spots, target-shaped or circular rashes on the trunk, often with central blisters, skin peeling, mouth, throat, nose, genital, and eye ulcers. These severe skin rashes may be preceded by fever and flu-like symptoms [exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis];
• widespread rash, high body temperature, and swollen lymph nodes (DRESS syndrome);
• widespread, red, scaly rash with bumps under the skin and blisters, accompanied by fever. Symptoms usually occur at the beginning of treatment (generalized pustular eruption);
• allergic reactions, even severe ones, which may include: urticaria, itching, purpura, swelling of the face, mouth, and throat (angioedema), difficulty breathing (bronchospasm or dyspnea), irregular heartbeats (tachycardia), low blood pressure (hypotension), anaphylaxis, shock, and worsening of asthma;
• disorientation, headache, nausea, vomiting, neck stiffness, and fever, which could be symptoms of aseptic meningitis (which may occur more frequently in patients with systemic lupus erythematosus or other collagen diseases).

Other adverse effects include:
Uncommon (may affect up to 1 in 100 people):

• headache, dizziness, drowsiness, seizures, agitation, and fatigue;
• abdominal pain, nausea, and difficulty digesting (dyspepsia);
• skin rashes;
• vision disturbances.

Rare (may affect up to 1 in 1,000 people):

• cystitis, rhinitis;
• depression, insomnia, difficulty concentrating, mood instability, hearing disturbances;
• cerebral hemorrhage;
• dry eyes;
• awareness of one's own heartbeat (palpitations);
• diarrhea, flatulence, dry mouth, constipation, and vomiting; gum ulcers;
• hair loss (alopecia), photosensitivity dermatitis; skin reaction presenting with redness, desquamation, exfoliation, and itching (exfoliative dermatitis);
• skin becomes sensitive to light;
• severe kidney diseases including kidney disease caused by damage to renal tubule cells (tubular necrosis), inflammatory kidney disease affecting the glomeruli (glomerulonephritis), presence of blood in urine, and increased urine production; altered laboratory values of kidney function;
• cerebrovascular accident;
• decreased hematocrit levels.

Very rare (may affect up to 1 in 10,000 people):

• reduction in blood cell count (anemia, aplastic anemia, hemolytic anemia (possible positive Coombs test), decreased number of neutrophil white blood cells (neutropenia), reduced number of white blood cells (leukopenia), reduced platelet count (thrombocytopenia) with or without purpura, increased eosinophils in blood (eosinophilia), deficiency of all blood cell elements (pancytopenia), agranulocytosis – early signs include: fever, sore throat, superficial mouth ulcers, flu-like symptoms, severe fatigue, nosebleeds, and hemorrhages;
• drop in arterial pressure (hypotension);
• signs or symptoms of stomach or intestinal ulcers, perforation, or bleeding, black and foul-smelling stools, vomiting blood;
• bleeding lesions in the mouth, stomach burning (gastritis);
• simultaneous kidney and liver disease (hepatorenal syndrome), death of some liver cells (hepatic necrosis), liver disease (liver failure, hepatic dysfunction, hepatitis, jaundice);
• severe kidney diseases (acute renal failure, papillary necrosis), particularly following long-term treatment, associated with increased blood urea concentration and swelling (edema);
• decreased hemoglobin levels in blood;
• heart attack (myocardial infarction);
• severe skin infections and soft tissue complications during chickenpox infection;
• worsening of inflammation related to infections (e.g., necrotizing fasciitis) associated with the use of certain non-steroidal anti-inflammatory drugs (NSAIDs). If signs of infection appear or worsen, seek immediate medical advice to determine whether anti-infective/antibiotic therapy is needed.

Not known (frequency cannot be estimated from available data):

• irritability;
• fluid retention and decreased appetite;
• abnormal perception of noises such as buzzing, ringing, or hissing (tinnitus);
• severe heart disease (heart failure) and swelling (edema);
• increased blood pressure (hypertension) and reduced blood flow to the body (shock);
• respiratory tract disorders including asthma, laryngeal obstruction, labored breathing (bronchospasm), temporary cessation of breathing (apnea), and difficulty breathing (dyspnea);
• worsening of inflammatory bowel diseases (colitis and Crohn's disease), inflammation of the pancreas (pancreatitis), inflammation of the duodenum (duodenitis), inflammation of the esophagus (esophagitis);
• a severe skin reaction known as DRESS syndrome may occur. Symptoms of DRESS include: skin rash, fever, swollen lymph nodes, and increased eosinophils (a type of white blood cell);
• a widespread, red, scaly rash with pustule formation under the skin and blisters, mainly localized in skin folds, trunk, and upper limbs, accompanied by fever at the beginning of treatment (generalized pustular eruption). Stop using FLUIFORT FEVER AND PAIN if you develop these symptoms and contact your doctor immediately. See also section 2.
• chest pain, which may be a sign of a potentially serious allergic reaction called Kounis syndrome.

Clinical studies and epidemiological data suggest that the use of ibuprofen, especially at high doses (2400 mg/day) and for long-term treatment, may be associated with a modest increase in the risk of arterial thrombotic events (e.g., myocardial infarction or stroke).
Reporting of adverse effects
If you experience any adverse effect, including those not listed in this leaflet, consult your doctor or pharmacist. You may also report adverse effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. How to store FLUIFORT FEVER AND PAIN

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "Exp.". The expiry date refers to the last day of that month and to the product in its original, unopened packaging, properly stored.
Usable period after first opening: 6 months.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Package contents and other information

What FLUIFORT FEVER AND PAIN contains
FLUIFORT FEVER AND PAIN Children 100mg/5ml oral suspension, orange-flavoured, sugar-free

• The active substance is ibuprofen. Each ml of suspension contains 20 mg of ibuprofen.
• The other components are: citric acid monohydrate, sodium citrate, potassium acesulfame, xanthan gum, sodium benzoate, orange flavour, maltitol syrup, glycerin, purified water.

FLUIFORT FEVER AND PAIN Children 100mg/5ml oral suspension, strawberry-flavoured, sugar-free

• The active substance is ibuprofen. Each ml of suspension contains 20 mg of ibuprofen.
• The other components are: citric acid monohydrate, sodium citrate, potassium acesulfame, xanthan gum, sodium benzoate, strawberry flavour, maltitol syrup, glycerin, purified water.

It is possible that not all pack sizes are marketed.
Description of the appearance of FLUIFORT FEVER AND PAIN and contents of the pack
Oral suspension, 150 ml bottle with dosing syringe.
Marketing Authorisation Holder
Dompé farmaceutici S.p.A., Via San Martino 12 - 20122 Milano
Manufacturer
Special Product’s Line S.p.A., Via Fratta Rotonda Vado Largo, 1 - 03012 Anagni (FR)